Keurig Green Mountain Inc. is slated to go private in a $13.9 billion buyout deal by a JAB Holding Co.-led investor group. The companies said Monday that the investor group plans to acquire Keurig Green Mountain for $92 per share in cash, which represents a premium of 77.9% over the coffee giant’s
Heritage Pharmaceuticals Inc. has rolled verapamil 40-mg immediate-release tablets, a calcium channel blocker medication. Heritage said that its verapamil product is a generic version of Pfizer Inc.’s Calan, indicated for the treatment of angina, arrhythmias and hypertension.
Chain Drug Review incorrectly ran an advertisement in its Nov. 22, 2015, print issue that inaccurately pictured Camber Pharmaceuticals Inc.’s 20-mg and 40-mg esomeprazole capsules.
Blood pressure kiosk maker PharmaSmart took part in a pilot with Astrup Drug’s Sterling Pharmacy and nonprofit health group HealthPartners to show the potential of community pharmacists in helping patients with hypertension.
Prestige Brands Holdings Inc. has agreed to acquire DenTek Oral Care Inc. from investment firm TSG Consumer Partners LLC for $225 million in cash.
Pfizer Inc. plans to acquire Allergan Inc. for about $160 billion in the biggest deal ever in the health care sector. Pfizer said Monday that the transaction will allow the New York-based drug giant to relocate to Ireland to cut its U.S. tax burden. “The proposed combination of Pfizer
Steven Collis, president and chief executive officer of AmerisourceBergen Corp., has been named to succeed Richard Gozon as chairman. The company said Wednesday that Collis is slated to become chairman upon Gozon’s retirement at AmerisourceBergen’s annual shareholders meeting on March 3, 2016.
More than half of the world’s population will live in countries where medicine use will exceed one dose per person per day by 2020, up from 31% a decade ago, as the “medicine use gap” between developed and pharmerging markets narrows, the IMS Institute for Healthcare Informatics projects.
Leading candy brands Wrigley and Mars Chocolate have provided some merchandising insights that give retailers guidance on in-store placement that better reflects the habits of today’s on-the-go shoppers. The Mars Inc.
Shareholders of Perrigo Co. plc have rejected a hostile bid by Mylan N.V. to acquire the company in a deal valued at about $27 billion. Perrigo said Friday that shareholders holding more than 60% of its outstanding shares declined to tender into Mylan’s offer by the 8 a.m. ET deadline. The offer
Beer giants Anheuser-Busch InBev has reached an agreement to acquire SABMiller plc in a deal valued at about $108 billion. Clearing the way for the agreement was a deal for SABMiller to sell its 58% stake in its MillerCoors LLC joint venture to partner Molson Coors Brewing Co. for $12 billion.
New Jersey Gov. Chris Christie has approved legislation to create a pathway for the substitution of interchangeable biologic drugs, drawing praise from the Biotechnology Industry Organization (BIO) and BioNJ, a state biotechnology organization.
Hershey Co. has launched Kisses Deluxe Chocolates, which the company calls “the largest innovation in 25 years from one of America’s most iconic chocolate brands.
Glenmark Pharmaceuticals Inc. USA has received approval from the Food & Drug Administration for clotrimazole and betamethasone dipropionate cream 1%/0.05%, a topical antifungal medication.
AmerisourceBergen Corp. has finalized its acquisition of PharMEDium Healthcare Holdings Inc., a national provider of outsourced compounded sterile preparations (CSPs) to acute care hospitals. AmerisourceBergen announced the $2.
Camber Pharmaceuticals has launched a redesigned website that it said is more user- and device-friendly. The drug maker said Thursday that the revamped site, at camberpharma.
